Goldman Sachs’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-337,576
| Closed | -$5.72M | – | 4803 |
|
|
2014
Q4 | $5.72M | Sell |
337,576
-542,609
| -62% | -$9.2M | ﹤0.01% | 1910 |
|
|
2014
Q3 | $10.5M | Buy |
880,185
+136,030
| +18% | +$1.62M | ﹤0.01% | 1579 |
|
|
2014
Q2 | $4.2M | Sell |
744,155
-809,527
| -52% | -$4.57M | ﹤0.01% | 2112 |
|
|
2014
Q1 | $5.7M | Buy |
1,553,682
+468,541
| +43% | +$1.72M | ﹤0.01% | 1896 |
|
|
2013
Q4 | $3.65M | Buy |
1,085,141
+971,560
| +855% | +$3.26M | ﹤0.01% | 2230 |
|
|
2013
Q3 | $480K | Buy |
113,581
+64,905
| +133% | +$274K | ﹤0.01% | 3354 |
|
|
2013
Q2 | $224K | Buy |
+48,676
| New | +$224K | ﹤0.01% | 3578 |
|